SCHEMBL22216258

SCHEMBL22216258

NC/C(=C\F)Cn1cc(C(=O)Nc2ccc(F)cc2)cn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.46
LMNA P02545 1/20 0.46
MAPT P10636 1/20 0.46
GFER P55789 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
PTPN1 P18031 2/20 0.44
RAB9A P51151 3/20 0.43
NPC1 O15118 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
PTPN6 P29350 1/20 0.43
PTPN11 Q06124 1/20 0.43
ROCK1 Q13464 2/20 0.42
CYP3A4 P08684 1/20 0.41
GAA P10253 1/20 0.41
CXCR2 P25025 3/20 0.41
CXCR1 P25024 2/20 0.41
TAS2R8 Q9NYW2 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
MITF O75030 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22216188 0.90 LMNA (0.46) CYP2C19LMNAMAPTGFERNPSR1
SCHEMBL23907278 0.90 LMNA (0.46) CYP2C19LMNAMAPTGFERNPSR1
SCHEMBL22216259 0.90 LMNA (0.45) CYP2C19LMNAMAPTGFERNPSR1
SCHEMBL22216335 0.81 KLKB1 (0.37) CYP2C19LMNAMAPTGFERNPSR1
SCHEMBL23907276 0.79 RAB9A (0.43) LMNARAB9ANPC1SMN1; SMN2GAA
SCHEMBL22216225 0.79 RAB9A (0.43) PTPN1RAB9ANPC1SMN1; SMN2CXCR2
SCHEMBL22216339 0.79 KLKB1 (0.41) CYP2C19LMNAMAPTGFERNPSR1
SCHEMBL22216318 0.79 LMNA (0.51) CYP2C19LMNAMAPTGFERNPSR1
SCHEMBL22216245 0.78 HIF1A (0.49) RAB9ANPC1SMN1; SMN2GAAMEN1
SCHEMBL22216397 0.78 AOC3 (0.51) CYP2C19LMNAMAPTGFERNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3892621-A1 HALOALLYLAMINE COMPOUNDS AND APPLICATION THEREOF Nanjing Transthera Biosciences Co., Ltd. (CN) 2021-10-13 EP disclosed
WO-2020143763-A1 HALOALLYLAMINE COMPOUNDS AND APPLICATION THEREOF 南京药捷安康生物科技有限公司 2020-07-16 WO disclosed